Developers of Baltimore’s Port Covington project are focusing on life sciences development, including a forthcoming project from Alexandria Real Estate.
Virginia Beach is seeking to build a bio cluster in the heart of everything Virginia Beach has to offer. The cluster reached an important milestone, recently opening a brand new accelerator lab constructed and managed by BioHealth Capital Region (BHCR) stalwart Facility Logix. VABeachBio and its partners see this new lab as a sign of great things to come.
Matan Companies announces today leasing has begun at Progress Labs at Riverside I in Frederick, Maryland. Receiving its site plan approval on March 9, the 215,000 square feet of biomanufacturing-ready space will include a 96,000 square foot existing building as well as a 119,000 square foot expansion building, which is slated to break ground in May 2021 and is expected to be fully complete by Spring 2022.
The Tumor-Infiltrating Lymphocytes (TIL) Cell Processing Modular Facility is the first large-scale, fully prefabricated and modular multi-module cGMP manufacturing facility of its kind ever built in the United States. The National Cancer Institute (NCI) will utilize the facility to deliver cutting-edge cancer treatment.
Matan Companies announced today the signing of a long-term lease with Ellume, an Australian-based company that develops diagnostic solutions for infectious diseases. The Frederick facility, totaling over 180,000 square feet in two full buildings at Progress Labs at Center 85, will be Ellume’s first in the United States and will produce diagnostic tests for infectious diseases, including at-home rapid tests for COVID-19.
Grenova Inc., a Richmond-based sustainable biotech company, plans to move to a larger facility in the city, investing $10.6 million and creating 250 jobs over the next three years, Gov. Ralph Northam announced Tuesday.
The Matan Cos. will add biotech manufacturing and research space to one of its existing office campuses in Germantown to meet the surge in demand from local life sciences firms.
A Virginia Beach biotech accelerator program announced more than five years ago as a way to attract a booming, high-salary industry to the area has completed lab construction and is finally looking for tenants.
Pharmaceutical manufacturer Civica Inc. will invest $124.5 million to establish its first in-house pharmaceutical manufacturing operation in the City of Petersburg, VA. The project will create 186 new jobs.
New Alliance Launches to Make it Easier for Biopharma Companies to Reshore Manufacturing Operations in US